Qingxia Xu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Zhengzhou University, Henan Cancer Hospital · ORCID：0000-0002-8925-1230

发表论文 63 篇 · 总被引 463 次 · h-index 13

代表论文

• Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms (2024 · Phytomedicine · 被引 19)
• Highly sensitive detection platform-based diagnosis of oesophageal squamous cell carcinoma in China: a multicentre, case–control, diagnostic study (2024 · The Lancet Digital Health · 被引 11)
• The Prognostic Value of Procalcitonin Clearance and Procalcitonin to Albumin Ratio in Sepsis Patients (2023 · Clinical Laboratory · 被引 11)
• Ginkgolides with anti-PAF activity from Ginkgo biloba L. (2024 · Fitoterapia · 被引 10)
• Elucidation of anti-pneumonia pharmacodynamic material basis and potential mechanisms of Xiebai San by combining spectrum–efficacy relationship and surface plasmon resonance (2024 · Journal of Ethnopharmacology · 被引 9)
• Integration of network pharmacology and experimental verifications reveals the Bian-Se-Tong mixture can alleviate constipation in STC rats by reducing apoptosis of Cajal cells via activating PI3K-Akt signaling pathway (2024 · Heliyon · 被引 8)